Issuu on Google+

ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email!

Roche: Hoping for Continued Innovation Through Genentech Published on July 2012

Report Summary In an effort to streamline R&D activities, Roche is to shut down its research facility in Nutley, New Jersey, resulting in the loss of 1,000 jobs. By 2013, the company will transfer these R&D activities to sites in Switzerland and Germany. Despite the cuts in New Jersey, Roche is looking to establish a new center focusing on translational research on the US east coast.Details the contribution of each of Roche's major subsidiaries, Genentech and Chugai (along with internal development), to the company's performance.Offers an overview of the company's new molecular entity pipeline.Highlights reasons for the current exodus of the Pharma industry out of the 'garden state' of New Jersey.The Big Pharma company is banking on its hugely successful Genentech-sourced R&D offering to return its top line to growth following two difficult trading years.Indeed, based on the company's past and even near-term performance this would be a wise strategy, with Genentech bringing to market a plethora of blockbuster biologic therapies and exciting, first-to-market launches.But in light of intensifying competition in the company's core oncology therapy area and increasingly cost-conscious markets, Roche's move to invest in expensive biotech-driven R&D could be considered to be high risk.Assess the sources of Roche's historical and forecast sales growth, comparing its Genentech, Chugai and internal research armsEvaluate the benefits and risks of Roche's R&D strategyIdentify other R&D collaborative/partnership strategies currently being employed by Pharma

Roche: Hoping for Continued Innovation Through Genentech (From Issuu)

Page 1/3


Find Industry reports, Company profiles and Market Statistics

ReportLinker

>> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: ƒ ƒ

Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93

If you have any questions please visit http://www.reportlinker.com/notify/contact

Order Information Please verify that the product information is correct and select the format(s) you require. Roche: Hoping for Continued Innovation Through Genentech

Product Formats Please select the product formats and the quantity you require. 1 User License--USD 1 900.00

Quantity: _____

Corporate License--USD 4 750.00

Quantity: _____

Contact Information Please enter all the information below in BLOCK CAPITALS

Title:

Mr

Mrs

Dr

Miss

Ms

Prof

First Name:

_____________________________ Last Name: __________________________________

Email Address:

__________________________________________________________________________

Job Title:

__________________________________________________________________________

Organization:

__________________________________________________________________________

Address:

__________________________________________________________________________

City:

__________________________________________________________________________

Postal / Zip Code:

__________________________________________________________________________

Country:

__________________________________________________________________________

Phone Number:

__________________________________________________________________________

Fax Number:

__________________________________________________________________________

Roche: Hoping for Continued Innovation Through Genentech (From Issuu)

Page 2/3


Find Industry reports, Company profiles and Market Statistics

ReportLinker

>> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box.

Payment by credit card

Card Number: ______________________________________________

Expiry Date

__________ / _________

CVV Number _____________________

Card Type (ex: Visa, Amex…) _________________________________

Payment by wire transfer

Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189

Payment by check

UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE

Customer signature:

 

Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms

Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56

ƒ ƒ

Asia, Oceania and America : + 1 (805) 617 17 93

Roche: Hoping for Continued Innovation Through Genentech (From Issuu)

Page 3/3


Roche: Hoping for Continued Innovation Through Genentech